Market Overview

22 Stocks Moving In Friday's Pre-Market Session

Share:

Gainers

  • Habit Restaurants Inc (NASDAQ: HABT) rose 13 percent to $15.60 in pre-market trading after the company reported better-than-expected Q4 earnings.
  • BioScrip Inc (NASDAQ: BIOS) shares rose 11.6 percent to $1.63 in pre-market trading after the company posted strong Q4 results and announced a private placement of $5 million in common stock.
  • aTyr Pharma Inc (NASDAQ: LIFE) rose 9.9 percent to $3.90 in pre-market trading after the company disclosed that it has received the EMA orphan drug designation for resolaris.
  • Globus Maritime Ltd (NASDAQ: GLBS) rose 6.3 percent to $6.94 in pre-market trading after surging 4.15 percent on Thursday.
  • Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) shares rose 4.5 percent to $15.75 in pre-market trading after the company reported a narrower-than-expected loss for its fourth quarter.
  • Big Lots, Inc. (NYSE: BIG) rose 4.2 percent to $54.44 in pre-market trading after the company reported reported upbeat earnings for its fourth quarter.
  • ING Groep NV (ADR) (NYSE: ING) rose 4.2 percent to $14.72 in pre-market trading after declining 0.98 percent on Thursday.
  • Pingtan Marine Enterprise Ltd (NASDAQ: PME) shares rose 4.2 percent to $4.50 in pre-market trading after gaining 2.86 percent on Thursday.
  • Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) rose 4 percent to $4.71 in pre-market trading after surging 22.10 percent on Thursday.
  • Oclaro, Inc. (NASDAQ: OCLR) rose 4 percent to $9.23 in pre-market trading after gaining 0.79 percent on Thursday.
  • Vipshop Holdings Ltd - ADR (NYSE: VIPS) rose 3.4 percent to $13.59 in pre-market trading after gaining 1.23 percent on Thursday.
  • Marvell Technology Group Ltd. (NASDAQ: MRVL) shares rose 3.2 percent to $16.35 in pre-market trading after the company reported upbeat results for its fourth quarter and issued a strong outlook for the current quarter.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Losers

  • SCYNEXIS Inc (NASDAQ: SCYX) fell 27 percent to $2.39 in pre-market trading after the company disclosed that it has delayed the start of new clinical studies using IV formulation of SCY-078 at the FDA's request.
  • Nutanix Inc (NASDAQ: NTNX) fell 21.3 percent to $24.49 in pre-market trading. Nutanix reported upbeat quarterly results, but issued a weak forecast for the current quarter.
  • Immersion Corporation (NASDAQ: IMMR) shares fell 20.5 percent to $8.50 in the pre-market trading session. Immersion posted a wider-than-expected Q4 loss and issued a weak FY17 forecast. Craig-Hallum downgraded Immersion from Buy to Hold.
  • Karyopharm Therapeutics Inc (NASDAQ: KPTI) fell 15.1 percent to $11.75 in pre-market trading after the company reported Phase 2 SOPRA study results. The company disclosed the study did not meet primary endpoint.
  • HMS Holdings Corp (NASDAQ: HMSY) fell around 10.3 percent to $17.02 in pre-market trading. Raymond James initiated coverage on HMS Holdings with an Outperform rating.
  • WPP plc (NASDAQ: WPPGY) shares fell 8.2 percent to $107.35 in pre-market trading after the company reported preliminary results for 2016.
  • CGG SA (ADR) (NASDAQ: CGG) fell 7 percent to $8.53 in pre-market trading. CGG reported a Q4 loss of $279.1 million.
  • PennantPark Investment Corp. (NASDAQ: PNNT) shares fell 6.8 percent to $8.00 in pre-market trading. PennantPark Investment reported a quarterly distribution of $0.18 per share.
  • American Outdoor Brands Corp (NASDAQ: AOBC) shares fell 6.4 percent to $18.15 in pre-market trading after the company posted downbeat Q3 revenue and issued a weak forecast for the current quarter.
  • Costco Wholesale Corporation (NASDAQ: COST) fell 4.4 percent to $170.15 in pre-market trading after the company reported weaker-than-expected earnings and comparable store sales for its second quarter.

Posted-In: #PreMarket Gainers LosersNews Movers & Shakers Pre-Market Outlook Markets Movers

 

Related Articles (AUPH + AOBC)

View Comments and Join the Discussion!

A Dynamic Building ETF

An Expected Failure From Karyopharm's Selinexor Doesn't Change The Bull Thesis